BioDelivery Sciences International, a pharmaceutical firm focused on pain and neurology products, is being sold to Boston-based Collegium. The news sent shares in BDSI up more than 50% in pre-market trading Monday.
Read More
BioDelivery Sciences International will have a new CFO starting November 4, the company announced this week.
Read More
BioDelivery Sciences International plans to launch in the first quarter of 2022 in the U.S. and Canada an FDA-approved migraine treatment from Dr. Reddy’s Laboratories.
Read More
A host of companies across North Carolina are reporting earnings this week, including CommScope, Biocryst, BDSI and more. Here’s a look:
Read More
RESEARCH TRIANGLE PARK – It’s a big earnings week with companies across North Carolina reporting quarterly results. Here is the latest: Syneos Health tops Street MORRISVILLE – Syneos Health Inc. (SYNH) on Thursday reported second-quarter net income of $3.9 million. The Morrisville-based company said it had profit of 4...
Read More
Herm Cukier, chief executive officer at BioDelivery Sciences for the past two years, has been “terminated without cause” and an interim CEO will replace him effective Monday, the company disclosed in a regulatory filing.
Read More
A roundup of technology and life science news making headlines across North Carolina includes TransEnterix, Qorvo, Ironshore Pharmaceuticals, BioDelivery Sciences and a Charlotte investment technology firm.
Read MoreBioDelivery Sciences International has closed on $50 million in new financing through a stock sale and as part of that deal it has a new board chair as well as two board members.
Read More
Red Hat, Lenovo, BDSI, startup Carpe Lotion, Dale Earnhardt Jr., and a CRO merger top our roundup of NC tech headlines.
Read More
